首页> 外文期刊>Pharmacology Research & Perspectives >Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy
【24h】

Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy

机译:引入靶向微管的可变性:思考科尔接种治疗的当前机制和未来方向

获取原文
获取外文期刊封面目录资料

摘要

Microtubules (MTs) are highly dynamic polymers that constitute the cellular cytoskeleton and play a role in multiple cellular functions. Variability characterizes biological systems and is considered a part of the normal function of cells and organs. Variability contributes to cell plasticity and is a mechanism for overcoming errors in cellular level assembly and function, and potentially the whole organ level. Dynamic instability is a feature of biological variability that characterizes the function of MTs. The dynamic behavior of MTs constitutes the basis for multiple biological processes that contribute to cellular plasticity and the timing of cell signaling. Colchicine is a MT-modifying drug that exerts anti-inflammatory and anti-cancer effects. This review discusses some of the functions of colchicine and presents a platform for introducing variability while targeting MTs in intestinal cells, the microbiome, the gut, and the systemic immune system. This platform can be used for implementing novel therapies, improving response to chronic MT-based therapies, overcoming drug resistance, exerting gut-based systemic immune responses, and generating patient-tailored dynamic therapeutic regimens.? 2020 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.
机译:微管(MTS)是高度动态的聚合物,构成细胞骨骼骨骼,并在多种细胞功能中发挥作用。变异性表征生物系统,被认为是细胞和器官正常功能的一部分。可变性有助于细胞可塑性,是一种克服蜂窝水平组装和功能误差的机制,并且可能是整个器官水平。动态不稳定是生物变异性的特征,其特征是MTS的功能。 MTS的动态行为构成多种生物过程的基础,这些过程有助于细胞塑性和细胞信号传导的时序。血清序是一种MT改性药物,施加抗炎药和抗癌作用。本综述讨论了秋水仙碱的一些功能,并提出了一种用于引入可变性的平台,同时靶向肠道细胞,微生物组,肠道和全身免疫系统中的MT。该平台可用于实施新的疗法,改善对基于慢性Mt的疗法的反应,克服耐药性,施加基于肠道的全身免疫应答,以及产生患者量身定制的动态治疗方案。 2020作者。 John Wiley&Sons Ltd,英国药理学会和美国药理学学会和实验治疗学士发表的药理学研究与观点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号